Title:
PSMA COMBINER AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2021/175338
Kind Code:
A1
Abstract:
A prostate specific membrane antigen (PSMA) combining compound, a radioactive isotope complex thereof, and the use thereof in nuclear medicine as a tracer and an imaging agent for different disease states of prostate cancer.
Inventors:
SONG SHAOLI (CN)
XU XIAOPING (CN)
LIU CHANG (CN)
XU XIAOPING (CN)
LIU CHANG (CN)
Application Number:
PCT/CN2021/086783
Publication Date:
September 10, 2021
Filing Date:
April 13, 2021
Export Citation:
Assignee:
UNIV FUDAN SHANGHAI CANCER CT (CN)
International Classes:
C07K5/072; A61K38/05; A61K38/07; A61K49/00; A61K49/04; A61K51/04; A61K51/08; A61P35/00; A61P35/04; C07D213/82; C07D401/12; C07F13/00; C07K5/037; A61K103/10
Domestic Patent References:
| WO2019175405A1 | 2019-09-19 |
Foreign References:
| CN111253465A | 2020-06-09 | |||
| CN111777663A | 2020-10-16 | |||
| CN108026144A | 2018-05-11 | |||
| CN109641924A | 2019-04-16 | |||
| CN109982722A | 2019-07-05 |
Other References:
FERRO-FLORES GUILLERMINA; LUNA-GUTIÉRREZ MYRNA; OCAMPO-GARCÍA BLANCA; SANTOS-CUEVAS CLARA; AZORÍN-VEGA ERIKA; JIMÉNEZ-MANCILLA NAL: "Clinical translation of a PSMA inhibitor for99mTc-based SPECT", NUCL. MED. BIOL., ELSEVIER, NY., US, vol. 48, 3 February 2017 (2017-02-03), US, pages 36 - 44, XP029963241, ISSN: 0969-8051, DOI: 10.1016/j.nucmedbio.2017.01.012
"The Practice of Medicinal Chemistry", 1996, ACADEMIC PRESS, pages: 203
See also references of EP 4011903A4
"The Practice of Medicinal Chemistry", 1996, ACADEMIC PRESS, pages: 203
See also references of EP 4011903A4
Attorney, Agent or Firm:
SHANGHAI RONGHUI PATENT (CN)
Download PDF:
Previous Patent: MOSQUITO REPELLENT DEVICE
Next Patent: ROLE OF HUMAN SYMBIOTIC FLORA IN IMPROVING TUMOR IMMUNOTHERAPY RESPONSE
Next Patent: ROLE OF HUMAN SYMBIOTIC FLORA IN IMPROVING TUMOR IMMUNOTHERAPY RESPONSE